- Home
- ORA vs AKRO Comparison
ORA vs AKRO Comparison
Compare ORA & AKRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORA
- AKRO
- Stock Information
- Founded
- ORA 1965
- AKRO 2017
- Country
- ORA United States
- AKRO United States
- Employees
- ORA N/A
- AKRO N/A
- Industry
- ORA Electric Utilities: Central
- AKRO Biotechnology: Pharmaceutical Preparations
- Sector
- ORA Utilities
- AKRO Health Care
- Exchange
- ORA Nasdaq
- AKRO Nasdaq
- Market Cap
- ORA 4.6B
- AKRO 3.9B
- IPO Year
- ORA 2004
- AKRO 2019
- Fundamental
- Price
- ORA $89.47
- AKRO $47.72
- Analyst Decision
- ORA Buy
- AKRO Strong Buy
- Analyst Count
- ORA 8
- AKRO 6
- Target Price
- ORA $91.50
- AKRO $82.50
- AVG Volume (30 Days)
- ORA 459.9K
- AKRO 833.4K
- Earning Date
- ORA 08-06-2025
- AKRO 08-08-2025
- Dividend Yield
- ORA 0.53%
- AKRO N/A
- EPS Growth
- ORA N/A
- AKRO N/A
- EPS
- ORA 2.06
- AKRO N/A
- Revenue
- ORA $885,250,000.00
- AKRO N/A
- Revenue This Year
- ORA $9.30
- AKRO N/A
- Revenue Next Year
- ORA $15.14
- AKRO N/A
- P/E Ratio
- ORA $43.57
- AKRO N/A
- Revenue Growth
- ORA 1.95
- AKRO N/A
- 52 Week Low
- ORA $61.58
- AKRO $21.34
- 52 Week High
- ORA $91.81
- AKRO $58.40
- Technical
- Relative Strength Index (RSI)
- ORA 62.38
- AKRO 36.04
- Support Level
- ORA $87.61
- AKRO $50.60
- Resistance Level
- ORA $91.81
- AKRO $52.55
- Average True Range (ATR)
- ORA 1.23
- AKRO 1.80
- MACD
- ORA -0.38
- AKRO -0.63
- Stochastic Oscillator
- ORA 59.86
- AKRO 9.18
About ORA Ormat Technologies Inc.
Ormat Technologies Inc is engaged in the geothermal and recovered energy power business. It is engaged in three business segments: Electricity Segment. where the company develops, builds, owns and operates geothermal, solar PV and recovered energy-based power plants in the United States and geothermal power plants in other countries and sell the electricity generated. Product Segment includes designing, manufacturing and selling equipment for geothermal and recovered energy-based electricity generation and providing services relating to the engineering, procurement and construction of geothermal and recovered energy-based power plants. Energy Storage Segment includes owning and operating grid-connected which provide capacity, energy and ancillary services directly to the electric grid.
About AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.